GPT and metabolic dysfunction-associated steatotic liver disease: A total of 16 studies with 850 animals reported systemic ALT levels with high heterogeneity (I2 = 82%, p < 0.01), and the Panax ginseng treatment significantly reduced ALT levels in the HFD-induced NAFLD animal model (SMD: −2.33 mg/dL; 95% CI: −2.82 to −1.85 mg/dL; p < 0.0001) (Figure 5A).